Currently, according to the STIKO, the first booster vaccination is recommended for the following persons:
- All persons 12 years of age and older
- Children from 5 years of age with increased risk of severe COVID-19 courses as a result of an underlying disease. Please note the corresponding information under "What to consider when vaccinating children and adolescents."
According to the current recommendation, a minimum interval of 6 months from the last event (previous infection or COVID-19 vaccination) should generally be observed for booster vaccinations. In justified individual cases, the vaccination interval can be reduced to 4 months. Please discuss this with your primary care physician or specialist. For persons with immunodeficiency, the STIKO recommends a vaccination interval of at least 3 months to the last event.
For pregnant women of all ages, the STIKO recommends a booster vaccination from the 2nd trimester of pregnancy with the mRNA vaccine Comirnaty®. A minimum interval of 6 months from the last event (previous infection or COVID-19 vaccination) should be observed.
The STIKO recommends a booster vaccination with a vaccine adapted to the Omikron variant.
A second booster (4th vaccination) with an Omikron-adapted bivalent mRNA vaccine is recommended for the following groups:
- Persons 60 years of age and older
- Residents in nursing facilities as well as persons at increased risk for a severe COVID-19 course in institutions for the care of the disabled
- Staff in medical facilities as well as nursing facilities
- Persons 5 years of age and older at increased risk for severe COVID-19 courses due to an underlying disease, especially immunodeficiency.
Beyond the STIKO recommendations, a second booster vaccination (4th vaccination) with an Omikron-adapted bivalent mRNA vaccine is available for all persons with vaccination entitlement. The state of Rhineland-Palatinate currently allows this especially for persons who are particularly exposed due to their work, have close contact with vulnerable groups of persons, or persons in key positions. These may include, for example:
- Persons with close contact to vulnerable groups
- Staff in outpatient care or in the outpatient care of persons with dementia or mental disabilities
- Workers in community shelters
- Medical personnel in the public health service
- Teachers and educators
- Employees in retail trade
- Employees for the maintenance of public safety
- Personnel in key positions in state and federal governments
- Critical infrastructure workers
For the 2nd booster vaccination, the interval from the last immunological event (previous infection or COVID-19 vaccination) should be at least 6 months. For persons with immunodeficiency, the 2nd booster vaccination is recommended after only 3 months.
In particularly at-risk individuals - for example, the very elderly or people with immunodeficiency - it may make sense, according to the STIKO, to administer a further, i.e. fifth, vaccine dose after the fourth event (such as the 2nd booster vaccination). The decision should be made after individual medical consultation. Further information can be found in the corresponding press release of the RKI.
For the appropriate assessment and, if necessary, implementation of such a fifth vaccination, please contact your doctors in confidence, who can assess the individual state of health.
The STIKO recommends a booster vaccination with an mRNA vaccine in a minimum interval of 3 months after the completed basic immunization for persons aged 18 years and older who have been vaccinated with Nuvaxovid. Currently, there is no approval for Nuvaxovid for booster vaccination. According to the STIKO, Nuvaxovid® can be offered as a booster vaccination in individual cases after medical clarification if there are contraindications to mRNA-COVID-19 vaccines. This requires the presentation of a general practitioner's certificate to the vaccination center, which clearly states that Novavax should be vaccinated. The indication of a disease diagnosis alone is not sufficient.